Yahoo Web Search

Search results

    • Analyst Report: Viatris Inc.

      Morningstar Research via Yahoo Finance· 2 hours ago

      Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor ...